| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.25 | 0.04 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |